Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats

Arthritis and Rheumatism

Volumn 41, Issue 3, 1998, Pages 544-550

  Vingsbo Lundberg, Carina ^a   Saxne, Tore ^a   Olsson, Henric ^a   Holmdahl, Rikard ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BONE EROSION; BONE TURNOVER; CARTILAGE MATRIX; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EXTRACELLULAR MATRIX; MONITORING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SCORING SYSTEM;

EID: 0031884813     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199803)41:3<544::aid-art21>3.0.co;2-%23     Document Type: Article

References (28)

1. Harris ED Jr. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Saxne T, Heinegård D. Matrix proteins: potentials as body fluid markers of changes in the metabolism of cartilage and bone in arthritis. J Rheumatol 1995;22 Suppl 43:71-4.
3. Thonar EJ-MA, Shinmei M, Lohmander LS. Body fluid markers of cartilage changes in osteoarthritis. Rheum Dis Clin North Am 1993;19:635-57.
4. Poole AR, Dieppe P. Biological markers in rheumatoid arthritis. Semin Arthritis Rheum 1994;23:17-31.
5. Lohmander S, Saxne T, Heinegård D, editors. Molecular markers for joint and skeletal diseases. Acta Orthop Scand 1995;66 Suppl 266.
6. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, et al. Cartilage matrix proteins: an acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992;267:6132-6.
7. DiCesare P, Hauser N, Lehman D, Pasumarti S, Paulsson M. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett 1994;354:237-40.
8. Smith RKW, Zunino L, Webbon PM, Bee JA, Heinegård D. Identification of cartilage oligomeric matrix protein (COMP) in equine and bovine tendon. Transcripts of the 41st Annual Meeting of the Orthopaedic Research Society; 1995; Orlando, FL.
9. Recklies AD, Baillargeon L, White C. Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes [abstract]. Arthritis Rheum 1996;39 Suppl 9:S271.
10. Mörgelin M, Heinegård D, Engel J, Paulsson M. Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five-armed structure. J Biol Chem 1992;267:6137-41.
11. Oldberg Å. Antonsson P, Lindblom K, Heinegård D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 1992;267:22346-50.
12. DiCesare PE, Mörgelin M, Mann K, Paulsson M. Cartilage oligomeric matrix protein and thrombospondin 1: purification from articular cartilage, electron microscopic structure, and chondrocyte binding. Eur J Biochem 1994;223:927-37.
13. Barry FP, Gaw JU, Boynton RE, Neame PJ. A keratan sulphate binding protein from cartilage. Transcripts of the 41st Annual Meeting of the Orthopaedic Research Society; 1995; Orlando, FL.
14. Saxne T, Heinegård D. Cartilage oligomeric matrix protein: a novel marker of cartilage detectable in synovial fluid and blood. Br J Rheumatol 1992;31:583-91.
15. Månsson B, Carey D, Ionescu M, Rosenberg LC, Poole AR, Heinegård D, et al. Cartilage and bone metabolism in rheumatoid arthritis: differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 1995;95:1071-7.
16. Sharif M, Saxne T, Shepstone L, Kirwan JR, Elson CJ, Heinegård D, et al. Changes in serum levels of cartilage oligomeric matrix protein (COMP) predict disease progression in osteoarthritis of the knee joint. Br J Rheumatol 1995;34:306-10.
17. Petersson IF, Boegård T, Svensson B, Heinegård D, Saxne T. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol. In press.
18. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977;146: 857-68.
19. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunization against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-8.
20. Boissier M-C, Chiocchia G, Ronziere M-C, Herbage D, Fournier C. Arthritogenicity of minor cartilage collagens (type IX and type XI) in mice. Arthritis Rheum 1990;33:1-8.
21. Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in BALB/c mice: clinical features and histopathology. Arthritis Rheum 1987;30:201-12.
22. Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R. Pristane induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 1996;149:1675-83.
23. Saxne T, Castro F, Rydholm U, Svantesson H. Cartilage derived proteoglycans in body fluids of children: inverse correlation with age. J Rheumatol 1989;16:1341-4.
24. Thonar EJMA, Pachman LM, Lenz ME, Hayford J, Lynch P, Kuettner KE. Age related changes in the concentration of serum keratan sulphate in children. J Clin Chem Clin Biochem 1988;26: 57-63.
25. Smith RKW. The nature and role of noncollagenous proteins in equine tendon [thesis]. London: Univ. of London; 1997.
26. Saxne T, Månsson B. Analysis of body fluid markers of joint metabolism in joint diseases. Osteoarthritis Cartilage. In press.
27. Fex E, Saxne T. Tissue-derived macromolecules and markers of inflammation in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet. Br J Rheumatol 1997;36:1161-5.
28. Larsson E, Mussener Å, Klareskog L, Heinegård D, Saxne T. Serum levels of cartilage oligomeric matrix protein (COMP) and bone sialoprotein (BSP): markers of cartilage and bone involvement in experimental arthritis in rats. Br J Rheumatol. In press.